1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Shanghai Conant Optical Co. Ltd. Class H

Shanghai Conant Optical Co. Ltd. Class H

HHKEX:2276
36.64
HKD
+1.18
(+3.33%)
25.12BMarket Cap
Apr 06Next Earn
Shanghai Conant Optical Co. Ltd. Class H
HKEX:2276
(Hong Kong Exchange)

Recent

price

36.64

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
2
2.48
2.56
4.37
3.66
4.12
4.94
4.7
- -
Revenue per Share
0.18
0.26
0.3
0.59
0.58
0.77
1.03
1.2
- -
Basic EPS, GAAP
- -
0.08
0.45
0.07
0.15
0.82
0.61
0.52
- -
Free Cash Flow per Basic Share
0.98
0.87
- -
0.48
0.09
0.15
0.32
0.31
- -
Dividend per Share
0.27
0.89
1.18
2.2
2.69
3.27
3.72
5.9
5.9
Book Value per Share
0.26
0.88
1.18
2.2
2.68
3.27
3.72
5.89
5.89
Tangible Book Value per Share
427
427
427
310
427
427
417
465
466
Basic Weighted Avg Shares
854
1,059
1,093
1,356
1,561
1,760
2,061
2,186
- -
Sales/Revenue/Turnover
12.38
16.49
19.38
18.09
20.37
21.95
23.68
27.04
- -
Operating Margin (%)
39
62
46
47
48
59
74
84
- -
Depreciation Expense
78
112
128
184
249
327
428
558
- -
Net Income, GAAP
15.6
19.68
17.26
14.68
11.71
16.79
13.89
12.6
- -
Effective Tax Rate (%)
9.19
10.57
11.75
13.53
15.92
18.58
20.78
25.51
- -
Profit Margin (%)
-124
429
503
872
842
983
887
1,841
1,841
Working Capital
162
436
383
313
181
118
25
34
34
LT Debt
113
378
505
937
1,146
1,395
1,586
2,743
2,743
Total Equity
- -
18.08
15.44
14.85
17.76
19.82
23.44
21.84
- -
Return on Invested Capital (%)
- -
19.54
15
15.71
17.86
21.76
24.88
22.77
- -
Return on Capital (%)
- -
45.55
29.11
25.46
23.87
25.74
28.74
25.77
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
292
208
265
LT Borrowings
- -
- -
- -
LT Finance Leases
25
24
34
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
427
480
465
Market Capitalization
9,981
16,381
22,572

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
1,619
2,408
2,552
Cash, Cash Equivalents & STI
649
1,317
1,419
Accounts Receivable, Net
356
419
403
Inventories
563
553
602
Total Current Liabilities
732
664
711
Payables & Accruals
- -
- -
- -
ST Debt
292
208
265
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
43.29%
73.01%
Free Cash Flow
- -
105.99%
-4.25%
Net Income, GAAP
- -
34.21%
30.22%
Sales/Revenue/Turnover
- -
15.01%
6.08%
Total Cash Common Dividend
- -
- -
8.28%

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1,760
2024
- -
- -
2,061
2025
- -
- -
2,186

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.77
2024
- -
- -
1.03
2025
- -
- -
1.2

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.15
2024
- -
- -
0.32
2025
- -
- -
0.31
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Shanghai Conant Optical Co., Ltd. manufactures and sells resin spectacle lenses principally in Mainland China, the Americas, Asia, Europe, Oceania and Africa. The company offers standardized and customized lenses, including UV++ series, 1.74 series, single vision, student, progressive, hi-vex, business, specialty and anti-fog lenses; UV shield and gaming glasses; Smart Vision myopia-reducing lenses; Polarized Night-vision lenses for nighttime driving safety; color-shift lenses; Smart Parabolic 6k Progressive lenses; CSD wear- and scratch-resistant lenses; photochromic lenses; polarized lenses; industrial safety lenses; and anti-reflective coatings. It operates production bases in Shanghai and Jiangsu in China and Sabae in Japan; serves spectacle lens brand owners and international ophthalmic optic companies; and provides after-sales support services. Founded in 1996 and headquartered at Building 35, No. 1-42 Lane 83, Hongxiang North Road, Lin-gang Special Area, China (Shanghai) Pilot Free Trade Zone, Shanghai, China, the company listed H shares on the Hong Kong Stock Exchange in December 2021 under ticker 2276. In recent developments, Shanghai Conant Optical records revenue growth in its XR business segment through collaborations with leading global technology and consumer electronics enterprises, achieving approximately RMB10 million in aggregate revenue as of August 2025 from non-recurring engineering fees, trial orders and mass production; issues new H shares to Goertek (Hong Kong) Co., Limited in January 2025 raising net proceeds of approximately HK$827.9 million earmarked for research, development and manufacturing of lenses for smart glasses and XR headsets; advances construction of a Thailand production base and an automated customized lens production line at its Japanese subsidiary Asahi Optical with US$4 million investment; and launches employee share award schemes in 2023 and 2025 including repurchase of 15 million H shares for incentives.